DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
DeJesus E, Ruane P, McDonald C et al.
Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine.
HIV Clin Trials 2008;
9: 103-114
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.